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selective isopeptidase inhibitor with potent
pro-death activity, based on the bis
(arylidene)cyclohexanone scaffold
Sonia Ciotti1, Riccardo Sgarra2, Andrea Sgorbissa1, Carlotta Penzo2, Andrea Tomasella1, Federico Casarsa 3,
Fabio Benedetti3, Federico Berti3, Guidalberto Manﬁoletti2 and Claudio Brancolini1
Abstract
Diaryldienone derivatives with accessible β-carbons show strong anti-neoplastic properties, related to their ability to
make covalent adducts with free thiols by Michael addition, and low toxicity in vivo. Accumulation of poly-
ubiquitylated proteins, activation of the unfolded protein response (UPR) and induction of cell death are universal
hallmarks of their activities. These compounds have been characterized as inhibitors of isopeptidases, a family of
cysteine-proteases, which de-conjugate ubiquitin and ubiquitin-like proteins from their targets. However, it is unclear
whether they can also react with additional proteins. In this work, we utilized the biotin-conjugated diaryldienone-
derivative named 2c, as a bait to purify novel cellular targets of these small molecules. Proteomic analyses have
unveiled that, in addition to isopeptidases, these inhibitors can form stable covalent adducts with different intracellular
proteins, thus potentially impacting on multiple functions of the cells, from cytoskeletal organization to metabolism.
These widespread activities can explain the ability of diaryldienone derivatives to efﬁciently trigger different cell death
pathways.
Introduction
During the past decades the identiﬁcation of new small
molecule therapeutics has provided some improvements
for clinical treatments in patients with various tumors.
However, for certain cancers and particularly solid
tumors, exhibiting extreme drug resistance, the demand
of new agents is still urgent. A class of small organic
molecules, which derive from diaryldienone and contain
cross-conjugated α,β-unsaturated ketones with accessible
β-carbons, have evidenced anti-neoplastic properties and
low toxicity in different preclinical studies in vivo1–6. The
β carbon atoms of α,β-unsaturated ketones are available to
alkylate various cellular nucleophiles6–9. These small
molecules have been proposed as non-selective inhibitors
of isopeptidases, a family of enzymes that are involved in
the de-conjugation of ubiquitin and ubiquitin-like pro-
teins from different targets1,10. Indeed, cells treated with
these molecules accumulate poly-ubiquitylated proteins
in the presence of unperturbed proteasomal catalytic
activity1,2,5,10,11. Since several isopeptidases are cysteine-
proteases, they are prone to react with the α,β-unsatu-
rated ketones, thus leading to enzyme inactivation.
Importantly, these compounds cannot efﬁciently inhibit
the activity of other cysteine proteases, such as caspases or
cathepsins, thus indicating a certain degree of speciﬁcity9.
In vitro they can inhibit the activity of recombinant
isopeptidases8,12 and the presence of different groups, in
addition to the pharmacophore, can modulate the
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promiscuity of these compounds9,13. Hence, we refer to
them as partially-selective isopeptidase inhibitors (P-SIIs).
In cells treated with these P-SIIs, accumulation of poly-
ubiquitylated proteins is evident, in partial analogy to
bortezomib treatment2,14. Bortezomid/Carﬁlzomib are
inhibitors of the proteasomal catalytic chamber approved
for the use in clinic9. For this reason P-SIIs are usually
considered as alternative proteasome inhibitors. However,
when the cellular responses to the two inhibitors are
compared by gene expression proﬁle studies, the sig-
natures are not entirely superimposable. For example, 2c,
a P-SII previously identiﬁed and characterized8, exhibits
broader effects in terms of activation of adaptive
responses. The response to oxidative stress and protein
misfolding are more pronounced in 2c compared to
bortezomib treated cells14.
The identiﬁcation of the cellular targets of compounds
with therapeutic potential is an important step to improve
their activities and to understand potential side effects.
Chemical proteomics is an innovative approach to
unmask the cellular targets of small molecule ther-
apeutics. In chemical proteomics, afﬁnity chromatography
is combined with proteomic techniques such as mass
spectrometry for the unbiased identiﬁcation of protein
targets15. To identify the cellular target of P-SIIs and to
clarify their selectivity, we isolated cellular proteins bound
by 2c and analysed them by mass spectrometry. Our
approach employed a 2c-biotin conjugate as a probe to
identify in vivo the cellular targets of P-SIIs.
Results
Generation of the 2c-biotinylated probe
In order to better characterize the mechanisms
through which, diaryldienone-derivatives P-SIIs trigger
cell death and to deﬁne their cellular targets, we gener-
ated a biotinylated probe of 2c (Fig. 1). 2c is a P-SII that
we have recently synthetized and optimized for in vivo
delivery8. We initially compared the ability of 2c-biotin,
with respect to the original compound, of triggering cell
death. MEC-1 chronic lymphocytic leukemia cells were
treated for different times with the two compounds and
the appearance of cell death was evaluated by cyto-
ﬂuorimetric analysis. Cell death was similarly induced by
2c and its biotinylated version (Fig. 1b). Next, we veriﬁed
that the death response occurred through the activation
Fig. 1 Generation and characterization of biotin-conjugated 2c. a
Structure of 2c and of the 2c-biotin conjugate. b MEC-1 cells were
treated for the indicated times with 2 µM 2c, 2c-biotin, or DMSO alone
as control. After 24 h cells were stained wit PI ﬁxed and processed for
cytoﬂuorimetric analysis. Mean ± SD; n = 3. c Cellular lysates of MEC-1
cells treated with 2 µM 2c or of 2c-biotin for the indicated times were
subjected to immunoblotting using the anti-Gas2 antibody. Actin
immuno-detection was used as loading control. Arrowhead points to
the caspase-cleaved product. d IMR90-E1A cells were treated with the
indicated concentrations of 2c, 2c-biotin, or DMSO as control. After 24
h cells were stained wit PI ﬁxed and processed for cytoﬂuorimetric
analysis. Mean ± SD; n = 3. e Cellular lysates of IMR90-E1A cells treated
with 10 µM 2c or 2c-biotin for the indicated times were subjected to
immunoblotting using the anti-ubiquitin antibody. Actin was used as
loading control. f qRT-PCR analysis of mRNA expression levels for
GLCM and HMOX1 in cells treated for the indicated hours with 10 µM
2c or 2c-biotin. Mean ± SD; n = 3. g qRT-PCR analysis of mRNA
expression levels of HSPA1A and HSPA6 in cells treated for the
indicated hours with 10 µM 2c or 2c-biotin. Mean ± SD; n = 3
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of apoptosis. Caspase-dependent processing of GAS2
was detected as early as after 3 h of treatment and was
also comparable for the two compounds (Fig. 1c)16.
Finally, we also compared the pro-death activities of 2c
and of 2c-biotin in a different cell line. IMR90-E1A cells
evidence a similar dose-dependent response, when
challenged with the two compounds (Fig. 1d). In sum-
mary, biotinylation of 2c does not perturb its ability to
trigger cell death.
Biotinylation does not alter the biological properties of 2c
Cell death induced by 2c and similar compounds is
characterized by: (i) the accumulation of poly-
ubiquitylated proteins, (ii) the induction of oxidative
stress response and (iii) of the unfolded protein response
(UPR)1,8,14,17. To verify that the presence of the biotin tag
does not inﬂuence the activation of these cellular
responses, we initially investigated the accumulation of
polyubiquitylated proteins. Figure 1e illustrates that both
2c and 2c-biotin elicit the accumulation of poly-
ubiquitylated proteins. Data suggest that the original
compound is slightly more efﬁcient in blocking protea-
somal deubiquitylase activities. To evaluate the up-
regulations of the oxidative stress signaling, qRT-PCR
analysis was performed to measure the relative mRNA
levels of heme oxygenase HMOX1 and of GCLM, the
regulative subunit of the ﬁrst rate-limiting enzyme in
glutathione biosynthesis14. The expression of both genes
was upregulated in response to both 2c and 2c-biotin. In
this instance, the mRNA levels of both genes were higher
in cells treated with the biotinylated 2c (Fig. 1f). Finally,
we also investigated the upregulation of the UPR
(Unfolded Protein Response). We previously observed
that treatment with 2c triggers the upregulation of several
chaperons, including HSPA1A and HSPA614. Figure 1g
illustrates that the mRNA levels of HSPA1A and HSPA6
were both increased in IMR90-E1A cells treated with 2c
or its biotinylated analog. However, this upregulation was
stronger in the case of 2c-biotin. In summary, our studies
indicate that 2c and 2c-biotin elicit similar adaptive cel-
lular responses, even though some speciﬁcity can be
appreciated.
Nuclear accumulation of 2c-biotin
2c and similar compounds, containing electrophilic α,β-
unsaturated carbonyl units as Michael acceptors, show
very high and selective afﬁnity for thiol residues, in par-
ticular for cysteines. Impairment of the α, β-unsaturated
carbonyl reactivity in these compounds results in a strong
decrease of their pro-death potency6,8,18. Accordingly,
when 2c or 2c-biotin were pre-incubated with N-acetyl
cysteine (NAC) their pro-death activity was suppressed
(Fig. 2a). Hence, we used NAC as a tool to evaluate the
speciﬁcity of 2c-biotin activities in vivo.
Initially, cells were treated with biotin alone, 2c-biotin,
or 2c-biotin pre-incubated with NAC. After 6 h cells were
ﬁxed and processed for ﬂuorescence analysis using
streptavidin-tetramethylrhodamine (TRITC). Confocal
images were acquired and then analysed for ﬂuorescence
intensity. Fluorescence was dramatically augmented when
cells were treated with 2c-biotin and this ﬂuorescence was
suppressed when the compound was pre-incubated with
NAC (Fig. 2b).
Next we performed a time-course analysis to visualize
variations of the subcellular localization of 2c-biotin with
time. 2c-biotin positivity was detectable as soon as 5 min
after treatment and ﬂuorescence was evident in the
nucleus and also in the cytoplasm (Fig. 2c). After 10 min
the intensity of ﬂuorescence was further increased. At
later time-points (6 h) some signs of cellular stress, such
as reduced cell spreading, were evident. At this time
nuclear localization of 2c-biotin was even stronger,
whereas in the cytoplasm it accumulates in a perinuclear
area (see arrows and the higher magniﬁcation).
Pre-treatment with NAC completely abolishes the
ﬂuorescent signals. This behavior suggests that covalent
binding of 2c to cellular thiols is necessary for its intra-
cellular accumulation or that the NAC-2c complex is not
transported through the plasma membrane. thus con-
ﬁrming that covalent binding of 2c to cellular thiols is
necessary for its intracellular accumulation (Fig. 2d).
Finally, analysis of mitotic cells suggests that 2c does not
interact with chromatin, being chromosomes in meta-
phase negative for 2c-biotin signals (Fig. 2e).
Intracellular targets of the PS-II 2c
In order to identify PS-IIs intracellular targets, IMR90-
E1A cells were treated with 2c-biotin and, after lysis,
cellular extracts were incubated with streptavidin beads.
NAC was added to verify that binding of the targets was
due to the Michael acceptor activity of the probe. To
evaluate the binding to isopeptidases, we performed
immunoblot analysis on proteins puriﬁed after 2c-biotin
mediated pull-down. For enrichment comparison, each
pull-down was incubated in parallel with antibodies
against unrelated proteins.
We initially evaluated the enrichments of USP1 and of
actin, used as negative control, with respect to their
inputs. USP1 signal was highly enriched in a NAC-
dependent manner after 2c-biotin puriﬁcation (Fig. 3a). In
the case of actin, only a weak signal was observed in the 2c
pull-down. Next, we analysed the binding of 2c-biotin to
USP33 and to the serine-threonine kinase AKT, for
comparison (Fig. 3b). USP33, similarly to USP1, was
enriched after 2c-biotin pull-down in a NAC dependent
manner. Surprisingly, also AKT, after incubation with 2c-
biotin was enriched. Hence, we repeated the experiment
with USP1 using a different control, the chaperon GRP78.
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Fig. 2 Dynamics of 2c-biotin uptake and accumulation in cells. a IMR90-E1A cells were treated for 24 h as indicated. Cell death was scored as PI
positivity by cytoﬂuorimetric analysis. 2c and 2c-biotin were used at 10 µM. NAC was 2 mM. Mean ± SD; n = 3. b IMR90-E1A cells grown on coverslips
were treated for 6 h as indicated. Cells were ﬁxed and analysed with confocal microscope using the same parameters of acquisition. 2c-biotin was
revealed using streptavidin-TRITC. Quantitative analysis of the ﬂuorescence intensity was performed using the Metamorph software. c IMR90-E1A cells
were treated with 2c-biotin [2 µM] for the indicated times. After ﬁxation cells were incubated with streptavidin-TRITC. Nuclei were visualized using
Hoechst 33,342. Arrows point to cytosolic accumulation of 2c-biotin. The dotted square indicates the enlarged area. Images were obtained with an
epiﬂuorescence microscopy. Bar 30 µm. d IMR90-E1A cells were treated with 2c-biotin [2 µM] for 2 h. When used in pre-treatment, NAC was 2 mM.
After ﬁxation cells were incubated with streptavidin-TRITC. Nuclei were visualized using Hoechst 33,342. Images were obtained with an
epiﬂuorescence microscopy. Bar 30 µm. e IMR90-E1A cells were treated with 2c-biotin [2 µM] for 2 h. After ﬁxation cells were incubated with
streptavidin-TRITC. Nuclei were visualized using Hoechst 33,342. Images were obtained with an epiﬂuorescence microscopy. A mitotic cell is shown.
Bar 50 µm. Images are shown in pseudocolors
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USP1 was again enriched, whereas GRP78 was almost
undetectable in the 2c-biotin pull-down (Fig. 3c). Since
previous studies showed that 2c inhibits the deISGlase
activity of USP18, we also evaluated the 2c pull-down for
USP188. Here as control we used HDAC4. Binding to
USP18 was evident whereas binding of HDAC4 was very
weak (Fig. 3d).
Finally, we compared the binding of 2c to UCH-L5 and
USP14, the two cysteine-deubiquitylases of the protea-
some. Their inhibition should represent the key con-
tribution to the accumulation of poly-ubiquitylated
proteins9,13. The pull-down of both DUBs was enriched
compared to Actin (Fig. 3e). Previous studies, using dif-
ferent assays, indicated that compounds similar to 2c
Fig. 3 Identiﬁcation of target isopeptidases by biotin pull-down experiments. a/b/c/d/e IMR90-E1A cells were treated for 2 h with 10 µM 2c-
biotin or left untreated. 2c-botin was pre-incubated with 5 mM of NAC, as a negative control. Cellular proteins were puriﬁed by 2c-biotin pull-down
using streptavidin-agarose beads. Protein complexes were separated by SDS/PAGE and immunoblotted using the indicated antibodies. Inputs are
included for enrichment comparison. In the case of USP18 cells were pre-treated for 24 h with interferon-α. f IMR90-E1A cells were treated for 2 h
with the indicated concentrations of 2c-biotin or left untreated. As a control, 2c-biotin was pre-incubated with 5 mM NAC. Cellular proteins were
puriﬁed by 2c-biotin pull-down. Protein complexes were separated by SDS/PAGE and immunoblotted using the anti-USP14 or the anti-UCH-L5
antibodies. Inputs are included for enrichment comparison
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exhibit higher inhibition of USP14 activity compared to
UCH-L5. Hence, we compared in more detail the binding
of 2c-biotin to the two DUBs using different concentra-
tions of the inhibitor. Figure 3f conﬁrms that in vivo 2c-
biotin binds with comparable intensity USP14 and UCH-
L5.
In summary, we demonstrated that the compound 2c
shows a certain afﬁnity for isopeptidases. The spectrum of
enzymes recognized by 2c seems to be quite wide, thus
conﬁrming its partial selectivity. However, USP1/
USP33 showed a higher afﬁnity when compared to
USP18/UCH-L5/USP14. As expected, unrelated control
proteins such as Actin, HDAC4 and GRP78 showed a
weak reaction with 2c-biotin. Surprisingly, AKT can be
covalently modiﬁed by 2c-biotin.
Proteomic proﬁling of 2c adducts in transformed cells
The above study suggests that, in addition to iso-
peptidases, 2c might target additional proteins such as
AKT. To characterize the binding landscape of 2c, we
applied a chemical proteomic strategy. IMR90-E1A cells
were treated with 10 µM 2c-biotin for 2 h and lysed.
Biotinylated proteins were then isolated using avidin
column chromatography. As a control, the same
experiment was performed in the presence of NAC.
After SDS-PAGE separation and blue coomassie stain-
ing, lanes were divided in ﬁve parts, excised and trypsin
digested. The resulting peptides were analyzed by liquid
chromatography coupled to tandem mass spectrometry
(LC–MS/MS) and 25 proteins were successfully
identiﬁed.
Table 1 summarizes the results of such analysis. The
identiﬁed proteins fall into ﬁve different functional classes
including; metabolism (33%), proteostasis (33%), cytos-
keleton (19%), signaling (10%) and oxidative stress (5%)
(Fig. 4a). As expected some proteins were detected after
the NAC treatment as well. They could represent con-
taminants such as Tubulin and Actin. Hence, we excluded
them from the analysis. Pyruvate kinase and Eukaryotic
initiation factor 4A-1 were the two proteins detected with
the highest scores. To clarify whether the 2c-biotin
modiﬁed proteins, identiﬁed by mass-spectrometry,
reﬂect their relative abundance, we interrogated the pro-
tein abundance database PaxDb (http://pax-db.org.)19.
We also compared the abundance of the isopeptidases
USP1, USP14, USP18 USP33 and UCH-L5. Different cell
lines and different datasets were scrutinized20–24. Fig-
ure 4b shows the result of this analysis. As expected,
among the isopeptidases, the proteasome components
UCH-L5 and USP14 show higher abundance. Surpris-
ingly, USP14 in certain cell lines is much more abundant
than UCH-L5. USP1, USP18 and USP33 are quite rare
proteins. USP18, being interferon-inducible was almost
undetectable.
Although there is some variability among cell lines and
datasets, overall the newly identiﬁed 2c-biotin targets
represent high abundant proteins (GAPDH, ENO1, and
PKM) frequently ranking within the 5% more abundant
proteins. The only exception in the investigated cell lines
was myosin light chain 6B MYL6B.
Interestingly, among the 2c targets we identiﬁed Coﬁlin-
1. This protein is of particular interest since Coﬁlin-1 is
involved in mediating cytoskeletal changes and cell death
in response to a 2c analogous25.
Coﬁlin-1 phosphorylated at serine 3 interacts with 2c-
biotin
To corroborate the proteomic data, we performed 2c-
biotin pull-down experiments. We focused the analysis on
Coﬁlin-1, for the above-mentioned reasons. Surprisingly,
2c-biotin pull-down experiments did not evidence any
interaction with Coﬁlin-1 (Fig. 5a). Importantly, Coﬁlin-1
activities are regulated by phosphorylation of serine 3.
Therefore, we performed pull-down experiments using an
antibody recognizing Coﬁlin-1 when phosphorylated at
serine 3. Figure 5a indicates that 2c-biotin preferentially
reacts with the phosphorylated pool of Coﬁlin-1.
Coﬁlin-1 has 4 cysteines at positions 39, 80, 139, and
147 (Fig. 5b). Figure 5d highlights that two cysteine resi-
dues (Cys139, Cys147) are located on the surface and are
thus potentially available for the reaction with 2c. The
other two residues are partially (Cys39) and completely
buried (Cys80).
Discussion
Diaryldienone-derivatives comprise an interesting and
heterogeneous family of molecules, which selectively elicit
apoptosis in neoplastic cells. Marks of their activities are
induction of the UPR, oxidative stress, and the accumu-
lation of poly-ubiquitylated proteins. These multiple cel-
lular responses have been attributed to their ability to
function as Michael acceptors against the catalytic
cysteine of isopeptidases. Several groups have demon-
strated the ability of these molecules to impact on the
activity of these enzymes1–8,10,26. However, the presence
of additional targets has been underestimated.
To clarify this point and to better understand the
behavior of these molecules, we generated a biotinylated
version of 2c, a diaryldienone-derivative. Our studies
demonstrate that addition of biotin does not perturb the
activity of 2c. Induction of cell death, activation of cas-
pases, accumulation of poly-ubiquitylated proteins,
induction of the anti-redox and of the UPR response were
comparable between the original 2c and its biotinylated
version. Studies in vivo indicated that the compound is
rapidly up-taken by the cells. It shows a diffuse localiza-
tion and accumulates in the nuclei. Absence of punctate
staining points against an uptake through vesicle-
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Fig. 4 Candidate 2c-biotin targets identiﬁed by mass-spectrometry. a Identiﬁed proteins can be grouped into categories: metabolism,
proteostasis, cytoskeleton, oxidative stress, and signaling. Numbers of proteins of each category are indicated. b Relative abundance of the
isopeptidases evaluated for 2c-biotin binding by immunoblots (blue dots) in comparison with proteins identiﬁed by mass-spectrometry (green dots).
Data are presented as ranking. Data were obtained from http://pax-db.org. The selected cell lines and the original datasets are indicated
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mediated trafﬁcking. These data are in agreement with
previous hypotheses based on studies with a structurally
related compound18.
Biotin pull-down experiments demonstrated that 2c
covalently binds several isopeptidases, in a NAC-
dependent manner and with higher afﬁnity compared to
different control proteins. Although these studies need
further validation using different essays, we observed a
higher binding afﬁnity for USP1 and USP33 compared to
USP14, USP18, or UCH-L5. We cannot exclude that these
differences stem from a different in vivo accessibility of
the enzymes, due to the existence of multi-protein
complexes.
Surprisingly, the serine/threonine kinase AKT was
bound with high afﬁnity by 2c-biotin. AKT is an impor-
tant signaling enzyme, regulating survival and prolifera-
tion, whose activity is affected by G5, a 2c-like
compound25. AKT kinase activity depends on two cri-
tical residues; threonine 308 and serine 437. Treatment
with G5 promotes a transient phosphorylation of threo-
nine 308, followed by its dephosphorylation. By contrast,
serine 473 is dephosphorylated at earlier time-points.
While dephosphorylation of threonine 308 is PP2A-
dependent, serine 473 dephosphorylation is largely inde-
pendent25. Interestingly, cysteine residues 310 and 296
found in the T-loop region are critical for AKT activity
and can be subjects of bioreductive alkylation by pyr-
anonaphthoquinone lactones27,28. Hence, AKT contains
2c-addictable cysteines critical for its activity. Further
study will be necessary to understand whether the
reaction with 2c or similar compounds impairs AKT
enzymatic activity.
The mass-spec analysis conﬁrmed that additional cel-
lular proteins are modiﬁed by 2c-biotin. These proteins
can be grouped in ﬁve major functional classes (metabo-
lism, proteostasis, cytoskeleton, signaling, and oxidative
stress).
Previous studies indicated that these compounds can be
relatively promiscuous. Actin can be addicted by 15-
Deoxy-Δ12,13-prostaglandin J2 that contains the same
unsaturated ketone pharmacophore of 2c29. The bis
(benzylidene)piperidone RA190 reacts with cysteine 88 of
the proteasome ubiquitin receptor hRpn13 and MCB-613
(4-ethyl-2,6-bis-pyridin-3-ylmethylene-cyclohexanone), a
molecule structurally similar to 2c, can stimulate steroid
receptor co-activators (SRCs) transcriptional activity7,30.
Surprisingly, isopeptidases were not identiﬁed by this
analysis. It should be noted that, among the identiﬁed 2c
targets, high abundance proteins are the foremost repre-
sented. In principle, these high abundance targets could
compete with high afﬁnity but low abundant targets, such
as USP1 and USP33.
2c and similar molecules trigger profound changes of
cytoskeleton and cell morphology. Time-lapse experi-
ments demonstrated that, before the appearance of
apoptosis, stress ﬁbers disassemble and cells lose adhe-
sion31. An important contribution to these cytoskeletal
changes is provided by Coﬁlin-1. Coﬁlin-1 depho-
sphorylation triggers F-actin disassembling and 2c can
favor this dephosphorylation25. Importantly, 2c-biotin
Fig. 5 Only the phosphorylated version of Coﬁlin-1 reacts with 2c. a IMR90-E1A cells were treated for 2 h with 10 µM 2c-biotin or left untreated.
As a control, 2c-botin was pre-incubated with 5 mM NAC. Cellular proteins were puriﬁed by 2c-biotin pull-down, next immunoblotting were
performed using the indicated antibodies. Inputs are for enrichment comparison. b Primary sequence of human Coﬁlin-1. Cysteine residues are
highlighted in yellow and serine 3 in red. c Cartoon structure of Coﬁlin-1 (PDB: 1Q8G) showing the phosphorylation site (Ser3) in red and the four
cysteine residues in yellow. d Protein surface superimposed to the cartoon representation, with the same color code. The distance between Ser3 and
the available cysteines is 26 Å (Cys139) and 34 Å (Cys147). Images were obtained with the PyMOL Molecular Graphics System, Schrödinger, LLC
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preferentially modiﬁes the phosphorylated pool of Coﬁlin-
1. This observation suggests that 2c could impact F-actin
dynamic directly, by hijacking Coﬁlin-1 functions. Coﬁlin
dimers/oligomers exhibit bundling activities and dimer-
ization occurs via the formation of intermolecular dis-
ulﬁde bridges involving Cys (39) and, probably, Cys (147)
of adjacent Coﬁlin units. Indeed, these cysteines can react
with cucurbitacins, triterpenoid natural compounds32.
Smilarly, by reacting with the cysteines of Coﬁlin, 2c
might impair dimerization and thus impact directly on F-
actin severing33–35. Cysteine residues (Cys139, Cys147)
are located on the surface and are thus potentially avail-
able for the reaction with 2c. Interestingly, the distance
between Ser3 and these cysteines is 26 Å (Cys139) and 34
Å (Cys147).
In summary, our studies demonstrate that
diaryldienone-derivatives can be addicted to several cel-
lular proteins in addition to isopeptidases. The combina-
tion of different targets can elicit multiple stresses, which
are not manageable in neoplastic cells, thus explaining
their efﬁcient anti-tumor activity observed in vivo.
Materials and methods
Reagents and antibodies
Chemicals used were: bortezomib (LC Laboratories),
Propidium Iodide and N-acetylcysteine (Sigma Aldrich).
Primary antibodies used were: anti-Gas236 anti-actin
(Sigma/Aldrich) anti-USP137 anti-USP33 (Millipore)
anti-AKT (Cell Signaling) anti-UCH-L5 (Abcam), anti-
USP1838 anti-HDAC439 anti-MEF2D (BD Bioscience),
anti-GRP78, anti-USP14, anti-Coﬁlin-1, anti-pCoﬁlin-1
(Santa Cruz Biotechnologies).
Synthesis of the biotinylated version of 2c
Brieﬂy, the biotinylated derivative of 2c was obtained by
the insertion of a cadaverine linker between biotin and 2c.
To this end, biotin was ﬁrst used to acylate one of the
amino groups of cadaverine, and then the resulting adduct
was linked to 2c via a carbamate linkage obtained by
reaction with 2c-OSu. Products and intermediates were
characterized by Electrospray Ionization mass spectro-
metry (ESI-MS) performed on an Esquire 4000 (Bruker
Daltonics) spectrometer and by 1H and 13C NMR (Varian,
500MHz). Full details are reported in the supplementary
materials.
Culture conditions, ﬂuorescence microscopy, and cell
death analysis
MEC-1 cells were grown in RPMI medium whereas
IMR90-E1A cells were cultured in DMEM. Mediums were
supplemented with heated inactivated fetal calf serum
(Sigma Aldrich), penicillin (100 U/mL), glutamine (2
mmol/L), and streptomycin (100 μg/mL). Fluorescence
microscopy was performed as previously described1.
Brieﬂy, cells were ﬁxed in 3% paraformaldehyde, per-
meabilized with 1% Triton-X100 and incubated with
TRITC streptavidin (Molecular probes). For the quanti-
ﬁcation of cell death, cells were re-suspended in 500 μL of
PBS and stained with propidium iodide (PI). Fluorescence
was determined with a FACScan™ (Beckman Dickinson).
IFN-α2a (1000 units/mL; Jena Bioscience) was used as
previously described40.
2c-Biotin pull-down and immunoblotting
For pull-down experiments 4.5× 105 IMR90-E1A cells
were treated with 10 µM 2c-biotin for 2 h. When used, N-
acetylcysteine (NAC) was 5 mM. Cell lysis was performed
in lysis buffer (PBS, 2%SDS, 5 mM DTT). Proteins
obtained after an SDS denaturating lysis and sonication,
were incubated with streptavidin-agarose beads (GE
Healthcare). After several washes in lysis buffer, they were
eluted after boiling in sample buffer. Next SDS/PAGE
electrophoresis was performed and proteins were trans-
ferred to nitrocellulose membrane and incubated with the
speciﬁc primary antibodies. Secondary antibodies were
peroxidase-conjugated goat anti-rabbit or anti-mouse
(Sigma/Aldrich). Blots were developed with Super Signal
West Dura (Pierce).
RNA extraction and qRT-PCR analysis
RNA was extracted using Tri-Reagent (Molecular
Research Center) and retrotranscribed by using 100U of
Moloney murine leukemia virus reverse transcriptase
(Invitrogen). The primer sequences used are available
upon request. Quantitative reverse transcription-PCR
(qRT-PCR) analyses were performed using Bio-Rad
CFX96 and SYBR Green technology. HPRT and
GAPDH were used as normalizer genes. All reactions
were done in triplicate. Data were from al least three
experiments ±SD.
Proteomic analysis
2c–biotin pull down samples were separated by SDS—
PAGE and the gel stained by Coomassie blue. The lanes
corresponding to 2c—biotin and 2c—biotin plus NAC
were excised and divided into ﬁve parts. Proteins were in
gel digested and identiﬁed by LC-MS/MS analysis essen-
tially as previously described using a 1200 Series Nano
HPLC (Agilent)41. Only proteins having one or more
peptides with a score higher than 44 (identity or extensive
homology, P< 0.05) were included in the protein list.
Keratins and Streptavidin were excluded from the iden-
tiﬁed proteins. Protein have been listed according to the
Mascot protein score42,43.
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